(Q33616426)

28 July 2017

title

Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal (English)

1 reference

28 July 2017

0 references

1 reference

Pierre De Beaudrap

3

0 references

author name string

Jean-François Etard

1

1 reference

28 July 2017

Assane Diouf

2

1 reference

28 July 2017

Koivugui Akoi

4

1 reference

28 July 2017

Ndèye Fatou Ngom-Guèye

5

1 reference

28 July 2017

Ibrahima Ndiaye

6

1 reference

28 July 2017

René Ecochard

7

1 reference

28 July 2017

Papa Salif Sow

8

1 reference

28 July 2017

Delaporte Eric

9

1 reference

28 July 2017

publication date

31 December 2009

1 reference

28 July 2017

published in

The open AIDS journal

1 reference

28 July 2017

volume

3

1 reference

28 July 2017

page(s)

63-70

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

28 July 2017

copyright license

start time

31 December 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Modeling the joint epidemics of TB and HIV in a South African township

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Change over time of mortality predictors after HAART initiation in a Senegalese cohort.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2812839

30 October 2018

1 reference

12 December 2020

Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings

1 reference

PubMed

12 December 2020

Incidence of tuberculosis during highly active antiretroviral therapy in high-income and low-income countries

1 reference

PubMed

12 December 2020

Tuberculosis control in South Africa--will HAART help?

1 reference

PubMed

12 December 2020

10.2174/1874613600903010063

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference